OCT Europe (Outsourcing in Clinical Trials) 2025
Join us at OCT Europe 2025, happening April 29-30 in the Barcelona, Spain!
Visit booth #73 to meet TFS’s experienced CRO team and explore our specialized clinical development and resourcing solutions designed to elevate your clinical research. We combine the full-service capabilities and global reach of a large CRO with the flexibility and personal approach only a mid-size CRO can deliver.
Why TFS?
Experience scientific and medical excellence across diverse therapeutic areas. Our seasoned professionals ensure solution-driven outcomes, allowing sponsors to concentrate on advancing clinical innovations. TFS CRO provides industry-leading capabilities in the following areas:
Contact us today to connect during the conference and discover how TFS can be your strategic CRO partner in clinical development. See you at OCT Europe (Outsourcing in Clinical Trials) 2025!
Attend Our Presentation
- April 29 at 4:15 PM
- Stream A: Clinical Operations and Outsourcing
Rethinking Clinical Operations: A Smarter, Faster Playbook for Trial Success
The CRO-Sponsor model is broken. Sponsors want agility, transparency, and reliability—yet, outsourcing often creates delays, inefficiencies, and misalignment. This session introduces a new, results-driven framework for smarter clinical operations and outsourcing—helping sponsors cut through complexity, de-risk their trials, and bring treatments to market faster.
Key Takeaways:
- How to build an outsourcing model that actually works—rethinking sponsor-CRO collaboration for greater agility, transparency, and accountability.
- The “High-Retention” Trial Strategy—combining AI-powered recruitment, patient engagement tactics, and site-centric support to hit enrollment targets faster.
- From Neuroscience to High-Risk Indications & Beyond—real-world outcomes in optimizing trial execution.
- What’s Next?—The biggest shifts in clinical operations over the next 5 years and how to prepare.
About Our Presenter: Ara Vinuesa
Ara Vinuesa is a Senior Director of Project Management at TFS HealthScience, bringing over 17 years of experience in the pharmaceutical industry. With expertise in leading cross-functional teams globally, Ara oversees the operational and financial aspects of clinical projects from proposal to completion. Her experience spans all trial phases, including pediatric, medical device, and Real-World Evidence (RWE) studies, across multiple therapeutic areas such as transplantation, cardiovascular, infectious diseases, oncology, autoimmune conditions, and neuroscience. Ara holds degrees in Biology and Biochemistry from Universitat Central de Barcelona.